Screening Preeclamptic Cord Plasma for Proteins Associated with Decreased Breast Cancer Susceptibility

DSpace/Manakin Repository

Screening Preeclamptic Cord Plasma for Proteins Associated with Decreased Breast Cancer Susceptibility

Citable link to this page

 

 
Title: Screening Preeclamptic Cord Plasma for Proteins Associated with Decreased Breast Cancer Susceptibility
Author: Low, Hoi Pang; Tiwari, Ashutosh; Janjanam, Jagadeesh; Qiu, Li; Chang, Chien-I; Strohsnitter, William C.; Norwitz, Errol R.; Tam, Sun W.; Evans, James E.; Green, Karin M.; Paulo, Joao A.; Lambe, Mats; Hsieh, Chung-Cheng

Note: Order does not necessarily reflect citation order of authors.

Citation: Low, H. P., A. Tiwari, J. Janjanam, L. Qiu, C. Chang, W. C. Strohsnitter, E. R. Norwitz, et al. 2013. “Screening Preeclamptic Cord Plasma for Proteins Associated with Decreased Breast Cancer Susceptibility.” Genomics, Proteomics & Bioinformatics 11 (6): 335-344. doi:10.1016/j.gpb.2013.09.009. http://dx.doi.org/10.1016/j.gpb.2013.09.009.
Full Text & Related Files:
Abstract: Preeclampsia, a complication of pregnancy characterized by hypertension and proteinuria, has been found to reduce the subsequent risk for breast cancer in female offspring. As this protective effect could be due to exposure to preeclampsia-specific proteins during intrauterine life, the proteomic profiles of umbilical cord blood plasma between preeclamptic and normotensive pregnancies were compared. Umbilical cord plasma samples, depleted of 14 abundant proteins, were subjected to proteomic analysis using the quantitative method of nanoACQUITY ultra performance liquid chromatography–mass spectrometry with elevated energy mode of acquisitionE (NanoUPLC-MSE). Sixty-nine differentially expressed proteins were identified, of which 15 and 6 proteins were only detected in preeclamptic and normotensive pregnancies, respectively. Additionally, expression of 8 proteins (gelsolin, complement C5, keratin type I cytoskeletal 10, pigment epithelium-derived factor, complement factor B, complement component C7, hemoglobin subunit gamma-2 and alpha-fetoprotein) were up-regulated in preeclampsia with a fold change of ⩾2.0 when compared to normotensive pregnancies. The identification of alpha-fetoprotein in preeclamptic umbilical cord blood plasma supported the validity of this screen as alpha-fetoprotein has anti-estrogenic properties and has previously been linked to preeclampsia as well as a reduced breast cancer risk. The findings of this pilot study may provide new insights into the mechanistic link between preeclampsia and potentially reduced breast cancer susceptibility in adult life.
Published Version: doi:10.1016/j.gpb.2013.09.009
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357835/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:16121096
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters